The University of Chicago Header Logo

Connection

Ernst Lengyel to Adenocarcinoma, Clear Cell

Back to Details
This is a "connection" page, showing publications Ernst Lengyel has written about Adenocarcinoma, Clear Cell.
Ernst Lengyel
Connection Strength
0.249
Adenocarcinoma, Clear Cell
  1. Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer. Cancer Res. 2025 Sep 15; 85(18):3471-3489.
    View in: PubMed
    Score: 0.226
  2. Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure. Gynecol Oncol. 2012 Nov; 127(2):316-20.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.